| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $71.8M | +3680.4% |
| Cost of Revenue | $44.9M | -41.6% |
| Gross Profit | $26.9M | -21.5% |
| R&D Expense | $2.1M | +508.2% |
| SG&A Expense | $15.5M | -6.8% |
| Operating Income | $2.0M | -70.9% |
| Pre-tax Income | $2.0M | -51.4% |
| Income Tax | $520K | -49.3% |
| Net Income | $1.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.8M | -43.3% |
| Accounts Receivable | $5.3M | -19.2% |
| Inventory | $26.0M | -4.6% |
| Current Assets | $39.8M | -12.2% |
| Total Assets | $51.4M | -9.3% |
| Current Liabilities | $22.3M | -14.9% |
| Total Liabilities | $27.7M | -17.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98K | -101.5% |
| Capital Expenditures | $65K | -83.1% |
| Investing Cash Flow | -$731K | -223.6% |
| Financing Cash Flow | -$3.6M | -219.8% |
| Free Cash Flow | -$164K | -102.6% |
| -52.1% |
| EPS (Basic) | $0.04 | -50.0% |
| EPS (Diluted) | $0.04 | -50.0% |
| Stockholders' Equity |
| $23.7M |
| +2.7% |